Clinical trial
Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced…
NCT00093678 · Eastern Cooperative Oncology Group, Other · Withdrawn
Key facts
| NCT number | NCT00093678 |
|---|---|
| Title | Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer |
| Official title | A Randomized, Double Blind, Placebo-Controlled Trial of Celecoxib in Patients With Advanced Cancer |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Cachexia, Lymphoma, Melanoma (Skin), Ovarian Cancer, Pain, Sarcoma, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Procedure |
| Interventions | celecoxib, anticachectic therapy, nutritional support, pain therapy, supportive care/therapy |
| Enrollment | 0 |
| First posted | Oct 8, 2004 |
| Last update posted | Oct 8, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: